Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 2 1

Status

Not yet recruiting 2

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Leukemia, Myeloid, Acute 14Myelodysplastic Syndromes 6Advanced Solid Tumors 5Advanced Solid Tumour 4Small Cell Lung Carcinoma 3Recurrence 3Myeloproliferative Disorders 3Leukemia, Myelomonocytic, Chronic 3Carcinoma, Non-Small-Cell Lung 3Neoplasm Metastasis 2Multiple Myeloma 2Esophageal Squamous Cell Carcinoma 2Advanced Solid Tumor 2Unresectable Locally Recurrent Breast Cancer 1Squamous Cell Carcinoma of Head and Neck 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Ovarian Neoplasms 1Non-small Lung Cancer 1Non-Muscle Invasive Bladder Neoplasms 1Neuroma 1Neoplasms 1Nasopharyngeal Carcinoma 1Multiple Sclerosis 1Metastatic Solid Tumors 1Lung Neoplasms 1Leukemia, Myeloid, Accelerated Phase 1Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1Leukemia, Monocytic, Acute 1Leukemia, Biphenotypic, Acute 1Idiopathic Pulmonary Fibrosis 1

Interventions

Cisplatin 6Paclitaxel 4pembrolizumab 3Fluorouracil 3Carboplatin 3tislelizumab 2Taxes 2Radiotherapy 2Oxaliplatin 2Leucovorin 2Irinotecan 2Injections 2Capecitabine 2130-nm albumin-bound paclitaxel 2spartalizumab 1lenvatinib 1durvalumab 1cixutumumab 1apatinib 1Tegafur 1Surgical Procedures, Operative 1Saline Solution 1Radiation 1Levoleucovorin 1Laparoscopy 1Histamine H2 Antagonists 1Histamine Antagonists 1Fulvestrant 1Docetaxel 1Dexamethasone 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Esophageal Squamous Cell Carcinoma × Injections × 30 days × Clear all
NCT07621601 2026-06-02

A Study of HS-20093 in Patients With Pretreated Advanced or Metastatic Esophageal Squamous Cell Carcinoma (ESCC)

Hansoh BioMedical R&D Company

Phase 3 Not yet recruiting
494 enrolled
Gastrointestinal

Esophageal Squamous Cell Carcinoma, Neoplasm Metastasis

NCT07618910 2026-06-01

Retlirafusp Alfa Plus Chemotherapy as Neoadjuvant Therapy for Thoracic ESCC

Tang-Du Hospital

Phase 2 Not yet recruiting
33 enrolled
Gastrointestinal

Esophageal Squamous Cell Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡